Inventor
BHIDE RAJEEV S
US32 patents
⚠️ This page may combine multiple inventors who share the name “BHIDE RAJEEV S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
31 patentsUS6982265B1Jan 3, 2006
Pyrrolotriazine inhibitors of kinases
BRISTOL MYERS SQUIBB CO117 citations97
US6869952B2Mar 22, 2005
Pyrrolo[2,1-f][1,2,4]triazine inhibitors of kinases
BRISTOL MYERS SQUIBB CO92 citations97
US6969717B2Nov 29, 2005
Azaindole kinase inhibitors
BRISTOL MYERS SQUIBB CO36 citations95
US6951859B2Oct 4, 2005
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO38 citations92
US6602883B1Aug 5, 2003
Inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO23 citations92
US6458783B1Oct 1, 2002
Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO29 citations92
US6387926B1May 14, 2002
Inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO38 citations92
US7265113B2Sep 4, 2007
Inhibitors of kinases
BRISTOL MYERS SQUIBB CO12 citations91
US7244733B2Jul 17, 2007
Pyrrolotriazine inhibitors of kinases
BRISTOL MYERS SQUIBB CO40 citations91
US7030118B2Apr 18, 2006
Pyrrolotriazinone compounds and their use to treat diseases
BRISTOL MYERS SQUIBB CO42 citations91
US6933386B2Aug 23, 2005
Process for preparing certain pyrrolotriazine compounds
BRISTOL MYERS SQUIBB CO37 citations90
US8987311B2Mar 24, 2015
Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO14 citations83
US7521450B2Apr 21, 2009
Inhibitors of kinases
BRISTOL MYERS SQUIBB CO11 citations83
US7102002B2Sep 5, 2006
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO17 citations83
US7112675B2Sep 26, 2006
Pyrrolotriazine inhibitors of kinases
BRISTOL MYERS SQUIBB CO12 citations82
US7084160B2Aug 1, 2006
Heterocyclic inhibitors of kinases
BRISTOL MYERS SQUIBB CO6 citations73
US10023576B2Jul 17, 2018
Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors
BRISTOL MYERS SQUIBB CO2 citations72
US9657009B2May 23, 2017
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO4 citations71
US9546153B2Jan 17, 2017
Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO5 citations71
US7820814B2Oct 26, 2010
Inhibitors of kinases
BRISTOL MYERS SQUIBB CO2 citations61
USRE49700EOct 17, 2023
Substituted nitrogen containing compounds
BRISTOL MYERS SQUIBB CO0 citations60
US10501449B2Dec 10, 2019
Substituted nitrogen containing compounds
BRISTOL MYERS SQUIBB CO1 citations60
US10787450B2Sep 29, 2020
Spiro-fused cyclic ureas as inhibitors of rock
BRISTOL MYERS SQUIBB CO1 citations57
US10123993B2Nov 13, 2018
Cyclic ureas as inhibitors of rock
BRISTOL MYERS SQUIBB CO2 citations55
US10544133B2Jan 28, 2020
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations52
US10023562B2Jul 17, 2018
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations51
US7547711B2Jun 16, 2009
Heterocyclic inhibitors of kinases
BRISTOL MYERS SQUIBB CO0 citations51
US7053223B2May 30, 2006
Inhibitors of farnesyl protein transferase
BRISTOL MYERS SQUIBB CO0 citations42
US10214537B2Feb 26, 2019
Bicyclic heteroaryl amine compounds
BRISTOL MYERS SQUIBB CO0 citations41
US10654860B2May 19, 2020
Tricyclic rho kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations40
US10723723B2Jul 28, 2020
Substituted bicycle heterocyclic derivatives useful as ROMK channel inhibitors
BRISTOL MYERS SQUIBB CO0 citations39